NOVARTIS AG (NVSEF)
Clinical trial NCT05147220 updates: 1. primary completion date: 2026-04-30 → 2026-07-23 2. enrollment: not set → 1000 participants
Clinical trial NCT05147220 updates: 1. primary completion date: 2026-04-30 → 2026-07-23 2. enrollment: not set → 1000 participants
📉 **NEGATIVE** • Low confidence analysis (52%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical